Vortex Energy 주식 가격. VRTX - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

가격

0.055

매수가

0.055

매도가

0.06

거래량

54,550

0.055 일간 변동폭 0.06

0.055 52주 범위 0.85

전일 종가

0.055

개장가

0.06

최근 거래 시간

10000

0.055

마지막 거래 시간

평균 볼륨(3m)

129,877

재정 규모

VWAP

Vertex Pharmaceuticals Announces the Date of its Third Quarter 2006 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., Oct. 9 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will announce its third quarter 2006 financial results on Thursday, October 26, 2006...

Vertex Pharmaceuticals Announces Completion of Common Stock Offering

CAMBRIDGE, Mass., Sept. 20 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) today announced the completion of its public offering of 9,100,000 shares of common...

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences

CAMBRIDGE, Mass., Sept. 18 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will webcast corporate presentations at Merrill Lynch's Global Pharmaceutical, Biotech...

Vertex Pharmaceuticals Announces Pricing of Common Stock Offering

CAMBRIDGE, Mass., Sept. 14 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) today announced the pricing of its public offering of 9,100,000 shares of its common...

Vertex and Merck Initiate Clinical Study in Hematologic Cancers with Aurora Kinase Inhibitor VX-680

Vertex and Merck Initiate Clinical Study in Hematologic Cancers with Aurora Kinase Inhibitor VX-680 WHITEHOUSE STATION, N.J. and CAMBRIDGE, Mass., June 17 /PRNewswire/ -- Merck & Co., Inc...

Vertex Pharmaceuticals Reports Positive Results from First-in-Human Study for VX-950, an Investigational Oral Protease Inhibitor

Vertex Pharmaceuticals Reports Positive Results from First-in-Human Study for VX-950, an Investigational Oral Protease Inhibitor for the Treatment of Hepatitis C -- Encouraging Results Support...

Studies of Sustained Efficacy/Tolerability of LEXIVA After 96 Weeks of Treatment Presented at IAC

Studies of Sustained Efficacy/Tolerability of LEXIVA After 96 Weeks of Treatment Presented at IAC BANGKOK, Thailand, July 13 /PRNewswire-FirstCall/ -- The protease inhibitor (PI) LEXIVA(R...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.005	-8.33333333333	0.06	0.065	0.055	139302	0.05613782	CS
4	-0.04	-42.1052631579	0.095	0.095	0.055	175217	0.06428399	CS
12	-0.09	-62.0689655172	0.145	0.145	0.055	129877	0.08870519	CS
26	-0.155	-73.8095238095	0.21	0.27	0.055	85998	0.12396961	CS
52	-0.345	-86.25	0.4	0.85	0.055	154689	0.37494035	CS
156	-0.045	-45	0.1	2.32	0.055	200389	0.92344821	CS
260	-0.045	-45	0.1	2.32	0.055	200389	0.92344821	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
CODECypher Metaverse Inc	$ 0.70 (536.36%)	24.75k
ALEAlerio Gold Corp	$ 0.015 (200.00%)	61k
AUMCAuric Minerals Corp	$ 0.98 (145.00%)	149.71k
SLZSlave Lake Zinc Corp	$ 0.02 (100.00%)	13.5k
TUGATuga Innovations Inc	$ 0.01 (100.00%)	24k
CVGRCity View Green Holdings Inc	$ 0.005 (-50.00%)	2.2M
CACR.AKWG Resources Inc	$ 1.35 (-41.56%)	400
TTXTantalex Lithium Resources Corporation	$ 0.015 (-40.00%)	253k
VLTAVolta Metals Ltd	$ 0.025 (-37.50%)	7k
UAVGlobal UAV Technologies Ltd	$ 0.14 (-36.36%)	2k
PKKPeak Fintech Group Inc	$ 0.105 (-19.23%)	4.55M
CLDVCloud3 Ventures Inc	$ 0.015 (0.00%)	2.4M
CVGRCity View Green Holdings Inc	$ 0.005 (-50.00%)	2.2M
MAXXMax Power Mining Corp	$ 0.205 (-8.89%)	1.75M
GRUVProtium Clean Energy Corp	$ 0.05 (-16.67%)	1.74M